BioPharma
Bavarian Nordic Agrees for a $3 Bn Take-Private Offer
Bavarian Nordic, the vaccine maker, on July 28 said that it has agreed in principle for roughly $3 bn take-private offer from private equity firms...
BioPharma
South Korea – A Biopharma Innovation Hub With 113% Growth
The biopharmaceutical sector of South Korea has seen a growth in innovators and drug licensing agreements by way of reaching a total deal value of...
BioPharma
Vinay Prasad Leaves the FDA – An Abrupt End to His Tenure
The head of the Food and Drug Administration office, overseeing vaccines and gene therapy, Vinay Prasad leaves the FDA after taking over his job just...
BioPharma
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is...
BioPharma
AI in Genomics Market – Setting Pace for Vast Genomic Data
There is no shred of doubt that artificial intelligence in genomics is indeed reshaping the healthcare spectrum, offering unmatched opportunities to decode the intricacies of...
BioPharma
Future Innovations In Pharmaceutical Packaging Post-2025
Because of new ideas, concerns about safety for consumers, and government rules, the pharmaceutical business is about to enter a new era in packing. As...
BioPharma
Protein Antibody Development: How To Choose The Best CDMO
Selecting the appropriate contract research and manufacturing option is crucial for biopharmaceutical companies starting new initiatives related to the creation of novel antibodies.
Biopharma companies are...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.